This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Pupil dilation: Difference between revisions
Jump to navigation
Jump to search
>Josikins grammatical overhaul |
>Graham m wiki ref format |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
'''Pupil dilation''' (also called '''mydriasis''') can be described as the enlargement of the size of a person's pupils under normal lighting conditions. Normally, the pupil size increases in the dark and shrinks in the light, however, a dilated pupil will remain excessively large even in a bright environment. | '''Pupil dilation''' (also called '''mydriasis''') can be described as the enlargement of the size of a person's pupils under normal lighting conditions. Normally, the pupil size increases in the dark and shrinks in the light, however, a dilated pupil will remain excessively large even in a bright environment. | ||
Pupil dilation is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of a wide variety of [[serotonergic]] compounds, such as [[psychedelics]], [[dissociatives]], [[deliriants]], [[entactogens]], various [[stimulants]]<ref>Zuba, D. | Pupil dilation is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of a wide variety of [[serotonergic]] compounds, such as [[psychedelics]], [[dissociatives]], [[deliriants]], [[entactogens]], various [[stimulants]]<ref>{{cite journal | vauthors=((Zuba, D.)) | journal=TrAC Trends in Analytical Chemistry | title=Identification of cathinones and other active components of ‘legal highs’ by mass spectrometric methods | volume=32 | pages=15–30 | date= February 2012 | url=https://linkinghub.elsevier.com/retrieve/pii/S0165993611003761 | issn=01659936 | doi=10.1016/j.trac.2011.09.009}}</ref> and some [[antidepressants]]. | ||
</onlyinclude> | </onlyinclude> | ||
===Psychoactive substances=== | |||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | |||
{{#ask:[[Category:Psychoactive substance]][[Effect::Pupil dilation]]|format=ul|Columns=2}} | |||
===Experience reports=== | ===Experience reports=== | ||
Anecdotal reports which describe this effect within our [[experience index]] include: | Anecdotal reports which describe this effect within our [[experience index]] include: | ||
{{#ask:[[Category:Experience]][[Effect::Pupil dilation]]|format=ul|Columns=2}} | {{#ask:[[Category:Experience]][[Effect::Pupil dilation]]|format=ul|Columns=2}} | ||
===See also=== | ===See also=== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
Latest revision as of 04:45, 4 June 2022
Pupil dilation (also called mydriasis) can be described as the enlargement of the size of a person's pupils under normal lighting conditions. Normally, the pupil size increases in the dark and shrinks in the light, however, a dilated pupil will remain excessively large even in a bright environment.
Pupil dilation is most commonly induced under the influence of moderate dosages of a wide variety of serotonergic compounds, such as psychedelics, dissociatives, deliriants, entactogens, various stimulants[1] and some antidepressants.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1B-LSD
- 1P-ETH-LAD
- 1P-LSD
- 1V-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 2,5-DMA
- 2-FA
- 2-FEA
- 2-FMA
- 25B-NBOH
- 25B-NBOMe
- 25C-NBOH
- 25C-NBOMe
- 25D-NBOMe
- 25E-NBOH
- 25I-NBOH
- 25I-NBOMe
- 25N-NBOMe
- 2C-B
- 2C-B-FLY
- 2C-C
- 2C-D
- 2C-E
- 2C-H
- 2C-I
- 2C-P
- 2C-T
- 2C-T-2
- 2C-T-21
- 2C-T-7
- 3,4-CTMP
- 3-FEA
- 3-FPM
- 3-MMC
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-AcO-DMT
- 4-AcO-DiPT
- 4-AcO-MET
- 4-AcO-MiPT
- 4-FA
- 4-FMA
- 4-HO-DET
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-EPT
- 4-HO-MET
Experience reports
Anecdotal reports which describe this effect within our experience index include:
- Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
- Experience: 18 mg 2C-I - Visually intense and strong bodily sensations
- Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
- Experience: 300mg DXM (Oral) - Brink of the third
- Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
- Experience:12 mg AMT - Nicely Surprised
- Experience:120mg - Garden of The Gods
- Experience:150μg tab 1P-LSD (oral) - Amazing and very long trip (20+ hours)
- Experience:2 hits of LSD + weed - Mindfuck
- Experience:250 seeds - Harsh body load
- Experience:2mg 25C-NBOMe - Experimental trip to test personal limits of NBOMes
- Experience:300µg LSD - Togetherness and the Silent Dusk
- Experience:337mg DMT fumarate - A Day With DMT
- Experience:4-AcO-DMT + 200mg Pill
- Experience:4.5g - The Grand Introduction to Beauty and Fear
- Experience:4F-EPH (15mg) - Untitled
- Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
- Experience:5g Mushrooms - Failed attempt at a Terence Mckenna style trip.
- Experience:70mg Lisdexamfetamine (oral) - My first stimulant experience
- Experience:800 seeds LSA - My First Trip Ever
- Experience:LSD (230 ug) - An amazing adventure by vikilikepsych
- Experience:~150mg MDA(oral) - a case of mistaken identity
See also
- Responsible use
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
- Pupil constriction
External links
References
- ↑ Zuba, D. (February 2012). "Identification of cathinones and other active components of 'legal highs' by mass spectrometric methods". TrAC Trends in Analytical Chemistry. 32: 15–30. doi:10.1016/j.trac.2011.09.009. ISSN 0165-9936.